2023
Awareness of racial/ethnic inequities in time to treatment among breast cancer providers.
Cohen I, Canavan M, Jacob A, Sondhi A, Silver H, Bramwell L, Lustberg M, Adelson K. Awareness of racial/ethnic inequities in time to treatment among breast cancer providers. JCO Oncology Practice 2023, 19: 584-584. DOI: 10.1200/op.2023.19.11_suppl.584.Peer-Reviewed Original ResearchBreast cancer providersCancer providersRace/ethnicityEthnic inequitiesTreatment inequitiesExact testSmilow Cancer HospitalYale Cancer CenterHospital-level factorsEducational interventionAdverse social determinantsFisher's exact testDe-identified databaseBrief educational interventionNon-Latinx WhitesPatient factorsWhite patientsProvider factorsCancer HospitalCancer CenterCancer patientsOncological careCare metricsClinical armTreatment metrics
2020
The association between clinical trial (CT) participation, pharmaceutical costs, and savings performance in the Oncology Care Model (OCM).
Adelson K, Canavan M, Mun S, Gross C, Sinanis N, Davidoff A. The association between clinical trial (CT) participation, pharmaceutical costs, and savings performance in the Oncology Care Model (OCM). Journal Of Clinical Oncology 2020, 38: 2-2. DOI: 10.1200/jco.2020.38.29_suppl.2.Peer-Reviewed Original ResearchOncology Care ModelDrug costsCancer CenterLung cancerEpisode costsMean MedicareYale Cancer CenterClinical trial participationSystemic cancer therapyPart D drug costsCancer therapyLower drug costsCommon cancer typesChi-square testPayment modelsClinical factorsNovel cancer therapiesTrial participationOvarian cancerPatient episodesNovel therapiesCare modelCTR groupPharmaceutical costsAlternative payment modelsThe impact of clinical trial (CTr) participation on savings performance in the oncology care model (OCM).
Adelson K, Canavan M, Mun S, Gross C, Sinanis N, Davidoff A. The impact of clinical trial (CTr) participation on savings performance in the oncology care model (OCM). Journal Of Clinical Oncology 2020, 38: e19367-e19367. DOI: 10.1200/jco.2020.38.15_suppl.e19367.Peer-Reviewed Original ResearchOncology Care ModelDrug costsMean MedicareYale Cancer CenterMean drug costClinical trial participationSystemic cancer therapyLower drug costsCommon cancer typesChi-square testValue-based payment modelsPayment modelsClinical factorsCancer CenterTrial participationLung cancerEpisode costsCare modelCTR groupAlternative payment modelsCancer typesMean differenceCancer therapyCareEpisodes
2019
Effects of rising drug costs on efforts to control overall cost at a large academic cancer center.
Adelson K, Canavan M, Supalla S, Sedghi T, Chaudhry B, Sinanis N, Gross C. Effects of rising drug costs on efforts to control overall cost at a large academic cancer center. Journal Of Clinical Oncology 2019, 37: 2-2. DOI: 10.1200/jco.2019.37.27_suppl.2.Peer-Reviewed Original ResearchOncology Care ModelLarge academic cancer centerAcute care useAcademic cancer centerPost-acute careMean costCancer CenterCare useDrug costsEmergency department useCost of hospitalizationMean total costValue-based payment programsCost of pharmaceuticalsCancer HospitalCancer careDepartment useTotal episodesInpatient careMedicare claimsCare modelCareEpisodesUtilization categoriesPharmaceutical spendingImpact of an oncology urgent care clinic on emergency department rates.
Sedghi T, Canavan M, Gross C, Davidoff A, Gould Rothberg BE, Strait M, Sinanis N, Adelson K. Impact of an oncology urgent care clinic on emergency department rates. Journal Of Clinical Oncology 2019, 37: 6615-6615. DOI: 10.1200/jco.2019.37.15_suppl.6615.Peer-Reviewed Original ResearchUrgent care clinicED visit ratesSmilow Cancer HospitalVisit ratesProvider visitsED utilizationED visitsCare clinicsUnique patientsEmergency departmentAcute medical attentionUnscheduled emergency departmentRegular clinic visitsCommon cancer typesLower ED utilizationEmergency department ratesFull study sampleTwo-sample t-testClinic visitsSupportive careOncology providersED useSymptom managementCancer HospitalCancer Center